C. Yongyat et al. / Bioorg. Med. Chem. 18 (2010) 3726–3734
3733
spectra for compound 18 are the same as reported in the litera-
ture.32 Characterizations of compound 19 are as the following: Rf
(50 MHz, CDCl3) d 65.91, 68.58, 71.10, 71.46, 73.89, 75.17, 78.35,
98.69 (br s), 128.41, 130.17, 137.70, 138.64, 165.68.
0.55 (CH2Cl2/MeOH = 9:1); ½a Drt
ꢄ
= +5.2588 (c 0.85 mg/ml, CHCl3);
mp = 131.0–131.6 °C; 1H NMR (200 MHz, CDCl3) d 1.001 (s, 9H),
3.67 (dd, J = 8.0, 2.2 Hz, 1H), 3.85–4.10 (m, 4H), 4.36 (dd, J = 6.0,
2.2 Hz, 1H), 5.76 (d, J = 5.8 Hz, 1H); 13C NMR (50 MHz, CDCl3) d
24.72, 27.18, 38.26, 69.80, 70.53, 70.59, 72.02, 76.42, 80.18,
99.67; HRMS-ESI (m/z): [M+Na]+ calculated for C11H18O6Na,
269.0996; Found: 269.0996.
4.2.3. Product from condition 8 in Table 1
½
a rDt = +54.40 (c 0.1, 1 mg/ml, CHCl3); mp = 100.3–106.8 °C; 1H
ꢄ
NMR (600 MHz, CDCl3) d 3.23–4.00 (m, 5H), 4.10–4.45 (m, 2H),
4.53–4.76 (m, 2H), 4.88 (s, 1H), 5.68 (br s, 1H), 6.87–7.15 (m,
10H), 7.20–7.50 (m, 3H), 7.88–8.05 (m, 2H); 13C NMR (150 MHz,
CDCl3) d 65.86, 68.53, 71.06, 71.30, 71.39, 73.86, 75.09, 75.24,
78.27, 98.65, 127.17, 127.22, 127.40, 127.44, 127.47, 127.52,
127.65, 127.69, 127.74, 127.83, 127.90, 128.08, 128.80, 128.15,
128.21, 128.23, 128.26, 128.31, 128.32, 128.38, 128.40, 128.45,
128.48, 128.56, 128.59, 128.62, 128.65, 128.72, 129.89, 129.94,
129.97, 130.06, 130.09, 130.13, 133.36, 137.64, 138.57, 165.63.
4.1.5. 3,4-O-Benzyl-a-D-mannopyranose 1,2,6-orthoesters (1
and 2)
To a solution of tricyclic orthoesters 18 and 19 in DMF (183 ml
for 18, 93 mL for 19), BnBr (14 ml, 115 mmol for 18, 7 mL, 58 mmol
for 19, 5 equiv) and NaH (8 g, 115 mmol for 18, 4 g, 58 mmol for 19,
5 equiv) were added at 0 °C. The reaction mixture was gradually
warmed up to rt during 12 h. The reaction mixture was extracted
with Et2O and water (3ꢃ), washed with brine, and dried over anhy-
drous Na2SO4(s). The combined organic layer was concentrated in
vacuo, and purified by flash silica column chromatography (hex-
anes/EtOAc) to obtain compounds 1 (3.8 g, 37%, three steps) and
2 (2.8 g, 56%, three steps) as white solids. NMR spectra for com-
pound 1 are the same as reported in the literature.32 Characteriza-
tions of compound 1 are as the following: Rf 0.55 (hexanes/
4.2.4. Product from condition 12 in Table 1
½
a rDt = +24.10 (c 1.0, 10 mg/ml, CHCl3); mp = 56.8–68.1 °C; 1H
ꢄ
NMR (600 MHz, CDCl3) d 1.12–1.28 (s, 9H), 3.28–4.12 (m, 5H),
4.30–5.02 (m, 5H), 5.31–5.52 (m, 1H), 7.10–7.40 (s, 10H); 13C
NMR (50 MHz, CDCl3) d 27.33, 39.05, 62.18, 65.73, 67.92, 69.86,
70.95, 71.50, 71.90, 73.81, 74.20, 75.17, 78.18, 78.79, 52.60, 98.06
(br s), 128.35, 138.10, 177.50, 177.74.
4.2.5. Product from condition 16 in Table 1
EtOAc = 4:1);
½
a rDt
ꢄ
= ꢁ1.4133 (c 1.5 mg/ml, CHCl3); mp = 83.2–
½
a rDt = +40.19 (c 1.0, 10 mg/ml, CHCl3); mp = 63.3–80.4 °C; 1H
ꢄ
84.0 °C; 1H NMR (400 MHz, CDCl3) d 1.02–1.05 (m, 9H), 3.64–
3.71 (m, 2H), 3.92–3.98 (m, 1H), 4.06–4.11 (m, 2H), 4.36–4.40
(m, 1H), 4.62 (d, J = 11.6 Hz, 1H), 4.76 (d, J = 11.6 Hz, 1H), 4.823
(s, 2H), 5.67 (d, J = 5.8 Hz, 1H) 7.26–7.44 (m, 10H); 13C NMR
(80 MHz, CDCl3) d 24.67, 38.17, 70.12, 72.22, 72.91, 74.28, 77.52,
79.18, 99.31, 126.76, 127.70, 127.76, 127.90, 128.37, 128.43,
138.21; HRMS-ESI (m/z): [M+Na]+ calculated for C25H30O6Na,
449.1935; Found: 449.1940.
NMR (600 MHz, CDCl3) d 1.08–1.33 (m, 9H), 3.15–4.13 (m, 5H),
4.18–5.05 (m, 6H), 5.32–5.58 (br s, 1H), 6.95–7.41 (m, 10H); 13C
NMR (50 MHz, CDCl3) d 27.22, 38.91, 65.53, 67.44, 70.60, 71.26,
73.60, 74.85, 78.97, 83.16, 98.25 (br s), 128.18, 137.83, 138.50,
177.14.
Acknowledgments
This research was supported by Thammasat University Re-
search Fund and Thailand Research Fund. Ms. Moragot Sungsilp
has contributed to this project, as an undergraduate senior project
at Sirindhorn International Institute of Technology, Thammasat
University. C. Yongyat and M. Sungsilp thank the National Science
and Technology Development Agency (NSTDA) for the undergrad-
uate scholarships (SIIT-NSTDA: S1Y48/F-002) from the Young Sci-
entist and Technologist Program (YSTP). We thank Chulabhorn
Research Institute (CRI) for chemical reagents and equipment.
We thank Mr. Paul Vincent Neilson for editing this manuscript. A
patent has been filed for the chemical procedures and compounds
reported in this paper.
4.2. Polymerizations
A monomer was dried in Kügelrohr under high vacuum at 90 °C
for 24 h. Dichloromethane was distilled from CaH2. The solvent
was transferred under inert atmosphere. To a solution of monomer
in the solvent at the desired temperature (0 °C by ice-water bath,
ꢁ10 °C by ice-acetone bath, and ꢁ40 °C by dry ice-acetonitrile
bath),
a
catalytic amount of initiator (BF3ꢀEt2O, Ph3CBF4, or
TMSOTf) was added and kept at the desired temperature for 2 h.
The reaction mixture was kept at nearly the desired temperature
in the refrigerator or freezer for 12 h. The reaction mixture was di-
luted with CH2Cl2, washed with saturated aqueous NaHCO3 (3ꢃ),
dried over anhydrous Na2SO4(s), and concentrated in vacuo. The
crude product was dissolved in a minimum amount of CH2Cl2
and added pentane until there was a white precipitate. The precip-
itate was allowed to settle overnight. After the mother liquor was
removed, the precipitated polymer was dried under high vacuum
to give a white powder.
Supplementary data
Supplementary data associated with this article can be found, in
References and notes
4.2.1. Product from condition 6 in Table 1
1. Berg, S.; Kaur, D.; Jackson, M.; Brennan, P. J. Glycobiology 2007, 17, 35.
2. Khoo, K. H.; Douglas, E.; Azadi, P.; Inamine, J. M.; Besra, G. S.; Mikusova, K.;
Brennan, P. J.; Chatterjee, D. J. Biol. Chem. 1996, 271, 28682.
3. Chatterjee, D.; Bozic, C. M.; McNeil, M.; Brennan, P. J. J. Biol. Chem. 1991, 266,
9652.
4. Boonyarattanakalin, S.; Liu, X.; Michieletti, M.; Lepenies, B.; Seeberger, P. H. J.
Am. Chem. Soc. 2008, 130, 16791.
5. Sohail, M. J. Mol. Genet. Med. 2006, 2, 87.
½
a rDt = +56.78 (c 0.1, 1 mg/ml, CHCl3); mp = 105.0–111.8 °C; 1H
ꢄ
NMR (200 MHz, CDCl3) d 3.30–4.22 (m, 6H), 4.24–4.67 (m, 3H),
4.70–5.20 (m, 3H), 5.73–5.88 (m, 1H), 6.83–7.67 (m, 17H), 7.92–
8.30 (m, 2H); 13C NMR (50 MHz, CDCl3) d 68.56, 71.07, 71.41,
73.87, 75.11, 78.29, 98.65 (br s), 127.16, 127.42, 127.72, 127.93,
128.223, 128.40, 128.74, 129.93, 130.05, 133.37, 137.62, 138.55,
165.58.
6. Andersen, P. Nat. Rev. Microbiol. 2007, 5, 484.
7. Tiruviluamala, P.; Reichman, L. B. Annu. Rev. Public Health 2002, 23, 403.
8. Yew, W. W.; Chau, C. H. Eur. Respir. J. 1995, 8, 1184.
9. Yew, W. W.; Leung, C. C. Respirology 2008, 13, 21.
10. Russell, D. G. Nat. Rev. Mol. Cell Biol. 2001, 2, 569.
11. Russell, D. G. Nat. Rev. Microbiol. 2007, 5, 39.
4.2.2. Product from condition 7 in Table 1
½
a rDt = +45.47 (c 0.1, 1 mg/ml, CHCl3); mp = 98.2–109.1 °C; 1H
NMR (200 MHz, CDCl3) d 3.43–4.13 (m, 5H), 4.22–5.32 (m, 5H),
ꢄ
12. Hoppe, H. C.; de Wet, B. J.; Cywes, C.; Daffe, M.; Ehlers, M. R. Infect. Immun.
1997, 65, 3896.
5.58–5.98 (m, 1H), 6.92–7.64 (m, 10H), 8.0–8.3 (m, 2H); 13C NMR